Nov 21, 2019 / 10:40AM GMT
David Michael Steinberg - Jefferies LLC, Research Division - Specialty Pharma Analyst
Good morning, everyone. We're delighted to have with us the management of Jazz Pharmaceuticals from sunny Palo Alto, California. I'm Dave Steinberg, Specialty Pharma Analyst at Jefferies. So we're going to do a fireside chat, which is a much better way to delve into all the questions. With me is Dan Swisher, President and Chief Operating Officer of Jazz. So Dan, welcome, and thanks for coming all the way from California.
Daniel N. Swisher - Jazz Pharmaceuticals plc - President & COO
Thank you.
Questions and Answers:
David Michael Steinberg - Jefferies LLC, Research Division - Specialty Pharma AnalystLet me start right at the top. Can you share your vision of where you think Jazz is going for the next 5 years?
Daniel N. Swisher - Jazz Pharmaceuticals plc - President & COO
Sure. And I just like to also introduce my colleagues, Kathee Littrell, Head of IR; and Hugh Kiely, who's
Trustpilot
